BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

672 related articles for article (PubMed ID: 22154678)

  • 1. Clonal spread of multidrug-resistant Acinetobacter baumannii in eastern Taiwan.
    Chang KC; Lin MF; Lin NT; Wu WJ; Kuo HY; Lin TY; Yang TL; Chen YC; Liou ML
    J Microbiol Immunol Infect; 2012 Feb; 45(1):37-42. PubMed ID: 22154678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular epidemiology and antimicrobial resistance determinants of multidrug-resistant Acinetobacter baumannii in five proximal hospitals in Taiwan.
    Lin MF; Chang KC; Lan CY; Chou J; Kuo JW; Chang CK; Liou ML
    Jpn J Infect Dis; 2011; 64(3):222-7. PubMed ID: 21617307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of rifampicin, tigecycline, and colistin-resistant Acinetobacter baumannii in Iran; spreading of MDR strains of novel International Clone variants.
    Bahador A; Taheri M; Pourakbari B; Hashemizadeh Z; Rostami H; Mansoori N; Raoofian R
    Microb Drug Resist; 2013 Oct; 19(5):397-406. PubMed ID: 23768166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii.
    Song JY; Kee SY; Hwang IS; Seo YB; Jeong HW; Kim WJ; Cheong HJ
    J Antimicrob Chemother; 2007 Aug; 60(2):317-22. PubMed ID: 17540672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative activities of colistin, rifampicin, imipenem and sulbactam/ampicillin alone or in combination against epidemic multidrug-resistant Acinetobacter baumannii isolates producing OXA-58 carbapenemases.
    Tripodi MF; Durante-Mangoni E; Fortunato R; Utili R; Zarrilli R
    Int J Antimicrob Agents; 2007 Dec; 30(6):537-40. PubMed ID: 17851050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High tigecycline resistance in multidrug-resistant Acinetobacter baumannii.
    Navon-Venezia S; Leavitt A; Carmeli Y
    J Antimicrob Chemother; 2007 Apr; 59(4):772-4. PubMed ID: 17353223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.
    Nemec A; Krízová L; Maixnerová M; Diancourt L; van der Reijden TJ; Brisse S; van den Broek P; Dijkshoorn L
    J Antimicrob Chemother; 2008 Sep; 62(3):484-9. PubMed ID: 18477708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan.
    Liu JW; Wang LS; Cheng YJ; Hsu GJ; Lu PL; Liu YC; Chen CM; Lee CM; Sun W; Jang TN; Chiang PC; Chuang YC; Lin HC; Shi ZY; Kung HC; Huang CH; Tsao SM; Lu CT; Liao CH; Hsueh PR
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 3():S188-91. PubMed ID: 19013353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colistin and tigecycline susceptibility among multidrug-resistant Acinetobacter baumannii isolated from ventilator-associated pneumonia.
    Dizbay M; Altuncekic A; Sezer BE; Ozdemir K; Arman D
    Int J Antimicrob Agents; 2008 Jul; 32(1):29-32. PubMed ID: 18539006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Acinetobacter baumannii and meropenem-resistant Pseudomonas aeruginosa in Canada: results of the CANWARD 2007-2009 study.
    McCracken M; Mataseje LF; Loo V; Walkty A; Adam HJ; Hoban DJ; Zhanel GG; Mulvey MR;
    Diagn Microbiol Infect Dis; 2011 Mar; 69(3):335-41. PubMed ID: 21353962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissemination of multidrug-resistant, class 1 integron-carrying Acinetobacter baumannii isolates in Taiwan.
    Huang LY; Chen TL; Lu PL; Tsai CA; Cho WL; Chang FY; Fung CP; Siu LK
    Clin Microbiol Infect; 2008 Nov; 14(11):1010-9. PubMed ID: 19040472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro effects of tigecycline in combination with colistin (polymyxin E) and sulbactam against multidrug-resistant Acinetobacter baumannii.
    Ni W; Cui J; Liang B; Cai Y; Bai N; Cai X; Wang R
    J Antibiot (Tokyo); 2013 Dec; 66(12):705-8. PubMed ID: 23981963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outbreak of imipenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex harboring different carbapenemase gene-associated genetic structures in an intensive care unit.
    Lee YT; Fung CP; Wang FD; Chen CP; Chen TL; Cho WL
    J Microbiol Immunol Infect; 2012 Feb; 45(1):43-51. PubMed ID: 22169123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
    Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS
    Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First Detection of GES-5 Carbapenemase-Producing Acinetobacter baumannii Isolate.
    Al-Agamy MH; Jeannot K; El-Mahdy TS; Shibl AM; Kattan W; Plésiat P; Courvalin P
    Microb Drug Resist; 2017 Jul; 23(5):556-562. PubMed ID: 27854148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of multidrug-resistant Acinetobacter baumannii clonal lineages: a 10 year study in Greece (2000-09).
    Gogou V; Pournaras S; Giannouli M; Voulgari E; Piperaki ET; Zarrilli R; Tsakris A
    J Antimicrob Chemother; 2011 Dec; 66(12):2767-72. PubMed ID: 21933784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbapenem and multidrug resistance in Gram-negative bacteria in a single centre in Italy: considerations on in vitro assay of active drugs.
    Mezzatesta ML; Caio C; Gona F; Cormaci R; Salerno I; Zingali T; Denaro C; Gennaro M; Quattrone C; Stefani S
    Int J Antimicrob Agents; 2014 Aug; 44(2):112-6. PubMed ID: 25059444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of multidrug- and carbapenem-resistant Acinetobacter baumannii in Canada: results from CANWARD 2007.
    McCracken M; DeCorby M; Fuller J; Loo V; Hoban DJ; Zhanel GG; Mulvey MR
    J Antimicrob Chemother; 2009 Sep; 64(3):552-5. PubMed ID: 19578083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of tigecycline in the control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit.
    Jamal W; Salama M; Dehrab N; Al Hashem G; Shahin M; Rotimi VO
    J Hosp Infect; 2009 Jul; 72(3):234-42. PubMed ID: 19493588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.